These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4664255)

  • 1. A colorimetric microdetermination of plasma chylomicron-triglyceride after membrane filter filtration.
    Maruhama Y; Yanbe A; Oneda A; Yamagata S
    Tohoku J Exp Med; 1972 Dec; 108(4):317-25. PubMed ID: 4664255
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tri-, di- and monoglycerides in human serum and their relation to the lipoprotein spectrum].
    Vogelberg KH; Gries FA
    Klin Wochenschr; 1970 Feb; 48(4):227-31. PubMed ID: 5523312
    [No Abstract]   [Full Text] [Related]  

  • 3. Fractionation of plasma triglyceride-rich lipoproteins of the dairy cow: evidence of chylomicron-size particles.
    Ferreri LF; Elbein RC
    J Dairy Sci; 1982 Oct; 65(10):1912-20. PubMed ID: 7174960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postchallenge plasma lipoprotein retinoids: chylomicron remnants in endogenous hypertriglyceridemia.
    Wilson DE; Chan IF; Buchi KN; Horton SC
    Metabolism; 1985 Jun; 34(6):551-8. PubMed ID: 3999977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of different electrophoretic techniques for classification of hereditary hyperlipoproteinaemias.
    Heiberg A
    Clin Genet; 1973; 4(5):450-60. PubMed ID: 4127396
    [No Abstract]   [Full Text] [Related]  

  • 6. Polyacrylamide-gel disc-electrophoresis as a screening procedure for serum lipoprotein abnormalities.
    Naito HK; Wada M; Ehrhart LA; Lewis LA
    Clin Chem; 1973 Feb; 19(2):228-34. PubMed ID: 4346068
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenotyping of lipemias by ultrafiltration and nephelometry of serum lipoproteins.
    Werner M; Montgomery CK; Jones AL; Nussenbaum S
    Clin Chem; 1970 Jul; 16(7):573-8. PubMed ID: 5456758
    [No Abstract]   [Full Text] [Related]  

  • 8. Fat-induced hyperchylomicronemia in a 16-year-old Arab boy.
    Keinan Z; Tamir I; Dickerman Z; Stein JA
    Isr J Med Sci; 1973 Feb; 9(2):185-9. PubMed ID: 4696153
    [No Abstract]   [Full Text] [Related]  

  • 9. Clearance of chylomicron triacylglycerol and cholesteryl ester from the plasma of streptozotocin-induced diabetic and hypercholesterolemic hypothyroid rats.
    Redgrave TG; Snibson DA
    Metabolism; 1977 May; 26(5):493-503. PubMed ID: 139529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dietary modification of the postprandial phase].
    Canzler H
    Klin Wochenschr; 1990; 68 Suppl 22():76-82. PubMed ID: 2087085
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characterization of pre-beta hyperlipoproteinemias using 3 methods of electrophoresis].
    Michaux A; Rouffy J; Loeper J; Dreux C
    Ann Biol Clin (Paris); 1973; 31(2):95-6. PubMed ID: 4356119
    [No Abstract]   [Full Text] [Related]  

  • 12. Chylomicron apolipoprotein B catabolism.
    Stalenhoef AF
    Diabetologia; 1984 Dec; 27(6):609-10. PubMed ID: 6530056
    [No Abstract]   [Full Text] [Related]  

  • 13. The 16-hour-standing test and lipoprotein electrophoresis compared for detection of chylomicrons in plasma.
    McNeely S; Seatter K; Yuhaniak J; Kashyap ML
    Clin Chem; 1981 May; 27(5):731-2. PubMed ID: 7226497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein-modifying enzymes, postprandial lipoprotein metabolism, and lipoprotein distribution and composition.
    Föger B; Tröbinger G; Ritsch A; Lechleitner M; Hopferwieser T; Menzel HJ; Utermann G; Pfeiffer KP; Patsch JR
    Atherosclerosis; 1995 Oct; 117(2):253-61. PubMed ID: 8801871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of the esterified fatty acid index in the classification and quantitation of hyperlipoproteinaemias.
    Billimoria JD; Fahmy MF; Jepson EM; Maclagan NF
    Atherosclerosis; 1971; 14(3):359-74. PubMed ID: 4109240
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease.
    Maranhão RC; Feres MC; Martins MT; Mesquita CH; Toffoletto O; Vinagre CG; Gianinni SD; Pileggi F
    Atherosclerosis; 1996 Sep; 126(1):15-25. PubMed ID: 8879430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of nitroblue tetrazolium prestaining of serum lipoproteins on polyacrylamide disc electrophoresis.
    Segal AW; Putman D; Levi AJ; Lewis B
    Clin Chim Acta; 1974 Jun; 53(3):361-7. PubMed ID: 4367870
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipoprotein electrophoresis should be discontinued as a routine procedure.
    Iammarino RM
    Clin Chem; 1975 Mar; 21(3):300-8. PubMed ID: 163158
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetics of chylomicron triglyceride removal from plasma in rats: effect of dose on the volume of distribution.
    Harris KL; Harris PA
    Biochim Biophys Acta; 1973 Oct; 326(1):12-6. PubMed ID: 4756116
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.
    Brunzell JD; Hazzard WR; Porte D; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1578-85. PubMed ID: 4352459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.